Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-30 @ 6:15 AM
Study NCT ID:
NCT01606761
Status:
COMPLETED
Last Update Posted:
2018-03-23
First Post:
2012-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-24
First Submit QC Date:
None
Study First Post Date:
2012-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-24
Results First Submit QC Date:
None
Results First Post Date:
2018-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-02-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-02-23
Last Update Post Date:
2018-03-23
Last Update Post Date Type:
ACTUAL